122 related articles for article (PubMed ID: 37718175)
1. Corrigendum to "Rapamycin regulates osteogenic differentiation through Parkin-mediated mitophagy in rheumatoid arthritis" [Int. Immunopharmacol. 113(Part B) (2022) 109407].
Chen Q; Fan K; Song G; Wang X; Zhang J; Chen H; Qin X; Lu Y; Qi W
Int Immunopharmacol; 2023 Nov; 124(Pt A):110941. PubMed ID: 37718175
[No Abstract] [Full Text] [Related]
2. Rapamycin regulates osteogenic differentiation through Parkin-mediated mitophagy in rheumatoid arthritis.
Chen Q; Fan K; Song G; Wang X; Zhang J; Chen H; Qin X; Lu Y; Qi W
Int Immunopharmacol; 2022 Dec; 113(Pt B):109407. PubMed ID: 36379150
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Regulate Interclonal Communication on Osteogenic Differentiation Among Heterogeneous Osteogenic Single-Cell Clones Through PINK1/Parkin-Mediated Mitophagy.
Fei D; Xia Y; Zhai Q; Wang Y; Zhou F; Zhao W; He X; Wang Q; Jin Y; Li B
Front Cell Dev Biol; 2021; 9():687258. PubMed ID: 34604210
[TBL] [Abstract][Full Text] [Related]
4. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
Zhang Y; Ji T; Ma S; Wu W
Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].
Li M; Shi X; Wu Y; Qi B; Zhang C; Wang B; Zhang B; Xu Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):111013. PubMed ID: 37806790
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis" [Int. Immunopharmacol. 118 (2023) 110065].
Chen J; Luo W; Hu C; Ren M; Xu H; Xu X; Li W; Chen Y; Shao J; Xiao Z; Lv X; Liang G
Int Immunopharmacol; 2023 Aug; 121():110575. PubMed ID: 37407366
[No Abstract] [Full Text] [Related]
7. Corrigendum to "7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signaling" [Int. Immunopharmacol. 107 (2022) 108557].
Chen J; Zhu G; Sun Y; Wu Y; Wu B; Zheng W; Ma X; Zheng Y
Int Immunopharmacol; 2023 Sep; 122():110702. PubMed ID: 37544812
[No Abstract] [Full Text] [Related]
8. Corrigendum to "7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signalling" [Int. Immunopharmacol. 107 (2022) 108557].
Chen J; Zhu G; Sun Y; Wu Y; Wu B; Zheng W; Ma X; Zheng Y
Int Immunopharmacol; 2023 Sep; 122():110640. PubMed ID: 37524574
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Genetic association analysis of ATG16L1 rs2241880, rs6758317 and ATG16L2 rs11235604 polymorphisms with rheumatoid arthritis in a Chinese population" [Int. Immunopharmacol. 93 (2021) 107378].
Mo YJ; Zhang W; Wen QW; Wang TH; Qin W; Zhang Z; Huang H; Cen H; Wu XD
Int Immunopharmacol; 2022 Mar; 104():108511. PubMed ID: 35000891
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation" [Int. Immunopharmacol. 8 (2008) 1854-1858].
Sun Q; Zheng Y; Liu Q; Cao X
Int Immunopharmacol; 2020 Apr; 81():106193. PubMed ID: 32139322
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
Int Immunopharmacol; 2023 Jun; 119():110302. PubMed ID: 37193623
[No Abstract] [Full Text] [Related]
12. Gold nanoparticles enhance proliferation and osteogenic differentiation of periodontal ligament stem cells by PINK1-mediated mitophagy.
Wang Q; Liu J; Yang X; Zhou H; Li Y
Arch Oral Biol; 2023 Jun; 150():105692. PubMed ID: 37004436
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis" [Int. Immunopharmacol. 113 (Part B) (2022) 109395].
Luo J; Tan J; Zhao J; Wang L; Liu J; Dai X; Sun Y; Kuang Q; Hui J; Chen J; Kuang G; Chen S; Wang Y; Ge C; Xu M
Int Immunopharmacol; 2023 Dec; 125(Pt A):111119. PubMed ID: 37907388
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].
Yu Y; Cai W; Zhou J; Lu H; Wang Y; Song Y; He R; Pei F; Wang X; Zhang R; Liu H; Wei F
Int Immunopharmacol; 2021 Oct; 99():107911. PubMed ID: 34353734
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].
Gu W; Zhang M; Gao F; Niu Y; Sun L; Xia H; Li W; Zhang Y; Guo Z; Du G
Int Immunopharmacol; 2023 Jul; 120():110366. PubMed ID: 37258402
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].
Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
Int Immunopharmacol; 2024 Jun; ():112499. PubMed ID: 38909009
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants" [Int. Immunopharmacol. 101(Part B) (2021) 108216].
He L; Sun B; Guo Y; Yan K; Liu D; Zang Y; Jiang C; Zhang Y; Kong W
Int Immunopharmacol; 2023 Jun; 119():110260. PubMed ID: 37150708
[No Abstract] [Full Text] [Related]
18. FUNDC1 regulates receptor-mediated mitophagy independently of the PINK1/Parkin-dependent pathway in rotenone-treated SH-SY5Y cells.
Park SY; Koh HC
Food Chem Toxicol; 2020 Mar; 137():111163. PubMed ID: 32001317
[TBL] [Abstract][Full Text] [Related]
19. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin.
Durcan TM; Tang MY; Pérusse JR; Dashti EA; Aguileta MA; McLelland GL; Gros P; Shaler TA; Faubert D; Coulombe B; Fon EA
EMBO J; 2014 Nov; 33(21):2473-91. PubMed ID: 25216678
[TBL] [Abstract][Full Text] [Related]
20. Dibutyl phthalate causes MC3T3-E1 cell damage by increasing ROS to promote the PINK1/Parkin-mediated mitophagy.
Cui Y; Li B; Du J; Huo S; Song M; Shao B; Wang B; Li Y
Environ Toxicol; 2022 Oct; 37(10):2341-2353. PubMed ID: 35716031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
